Fundamental Analysis of Nutex Health Inc - Growth / Value Index
NUTX - Valuation Highlights
Valuation Analysis
Price to Book Ratio is 0.0039 indicating that it is undervalued.
Book Value in last 3 years is trending up
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -0.0243 | -1.09 | -1408.72 % | |
| Price to Book | 0.0039 | 0.0004 | -99.84 % | 0.0060 |
| Price to Sales | 0.0011 | 0.135 | -2.78 % | |
| Enterprise Value to EBITDA Multiple | -0.452 | -2378.21 | -2427545.18 % |
NUTX - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 4.0
Company's Profit Before Tax is increasing for last 5 Quarters
Tsr Profitability Index - Very Poor Score of 18.75
Very Low Dividend Yield of 0 %
Negative Net profit for last two years
Company Net profit is Negative for last 5 Quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -16.04 | -0.0366 | 99.99 % | -0.455 |
| Return On Asset | -3.36 | -0.0073 | 99.99 % | -0.090 |
| Net Profit Margin | -4.56 | -12.48 | 93.56 % | -0.540 |
| Operating Profit Margin | 0.533 | -4.90 | 97.35 % | 2.15 |
| EBITDA Margin | 8.89 | 0.951 | 100.54 % | 12.83 |
Highlights
| Market Cap | 35400.21 K |
| Enterprise Value | -5235.65 M |
| Price/Book TTM | 0.0039 |
| Outstanding Share | 49719.40 K |
| Float/ Outstanding Share | 51.05% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 4.00 |
| Altman Z Score | -1.44 |
| Sloan Ratio | -0.0001 |
| Peter Lynch Fair Value | 0 |
NUTX - Growth Highlights
Growth Analysis
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 130305 M | 5.66 % | 96719.72 % |
| Gross Profit | 17246.25 M | 20.97 % | 76770.80 % |
| EBITDA | 11590.48 M | 100.57 % | 33785.24 % |
| Net Profit | -5941.56 M | 93.19 % | 1051.48 % |
| EPS | -29.33 | 93.37 % | NA |
NUTX - Stability Highlights
Stability Analysis
Debt to equity ratio has decreased and is lowest in last five years
Tsr Stability Index - Poor Score of 28.12
Altman Z Score of -1.44 suggest high risk
Interest Coverage of -0.935
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.212 | -38.71 % | 0.192 |
| Cash Ratio | 0.377 | -39.57 % | |
| Quick Ratio | 1.50 | -12.87 % | 1.63 |
| Shareholders Equity | 19.86 | -28.73 % | |
| Debt to EBITDA | 7593.95 | 7061263 % |
Historical Valuation Ratios of Nutex Health Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Nutex Health Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Nutex Health Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Nutex Health Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)